Browse our collection of papers in
GlaxoSmithKline (GSK)
C/OM/271. Operational management in GlaxoSmithKline
- WORDS:
- 4000
- DATE:
- 2010
- PRICE:
- 49.99 GBP
This paper analyses the practical issues faced by firms from operational perspectives, providing key recommendations for improvement. GlaxoSmithKline (GSK) is used as a case study for research and development (R&D). Operations management in the Pharmaceutical industry is discussed, followed by an overview of GSK. Operational strategy, issues within the R&D Department, operational change, R&D Process mapping, and key performance objectives are discussed. The paper concludes with recommendations and conclusions.
KEYWORDS: GlaxoSmithKline, GSK, research and development, R&D, Operations Management,
Other Papers On: GlaxoSmithKline (GSK)
Other Papers On: General Operations Management
Subject Catalogue
- Dissertations and Proposals
- Analysis of Companies
- Analysis of Industries
- Architecture, Design and Technology
- Computing and Mathematics
- E-Commerce and E-Business
- Economics
- Education
- Engineering
- Fashion and Culture
- Finance and Accounting
- General Business
- History
- Hospitality and Tourism
- Human Resource Management
- International Relations
- Law
- Literature, Language and Theatre Studies
- Management and Organisational Behaviour
- Marketing
- Media, Music and Art
- Operations Management
- Philosophy
- Politics
- Psychology
- Science, Medicine and Nursing
- Sociology
Keywords Tag Cloud
glaxosmithkline gsk management merger dissertation strategic financial pharmaceutical mergers plc om change pestel swot value study wellcome beecham glaxo performance aquafresh operations smithkline chain bring desired acquisition porter forces corporate effects astrazeneca proposal strategy global glaxowellcome uk system stock quality managing social market organisational johnson vs molecular audit innovation swine clinical safety intelligence flu impact newspaper responsibility publicity environmental disclosures annual shoeshine reports issues production vaccines faced healthcare shoring credit rating capability operational investment opportunities marketing mix competitive environment phytopharm organisations reasons measuring capm security theory disaster novartis companies pfizer studies hr model india arising challenges communication directions economic project innovations methodology systems critique soft role development critical approach process speeding implementation lean knowledge culture investigation risk entrepreneurship control glaxosmithklein equilibrium share price negotiation harbin property intellectual valuation backgrounds benefits petroleum stocks british construction company portfolio acquisitions pharmaceuticals prediction using smithline post pre final benefit overview international options position comparative current finance master glaxosmithklines c return announcement effect technical
GET OUR GooGLE TOOLBAR BUTTON
BOOK MARK US
WHAT OTHERS HAVE SAID
Thank you for the excellent paper. I've used your services before and will keep using them, you provide an excellent service. All the best.Victor
